Results 191 to 200 of about 554,192 (217)

Single-Domain Antibody Probe with Low Renal Uptake for Claudin 18.2-Targeted PET Imaging of Gastric Cancer: Preclinical and Pilot Clinical Evaluations. [PDF]

J Nucl Med
Zheng M, Ma H, Xu T, Mu H, Liu Q, Zhang K, Bian Y, Zhang H, Li W, Zhang B, Shan Y, Peng X, Qin S, Wang Y, Miao L.   +14 more
europepmc   +1 more source

What are the views of cancer care administrators and clinicians in England on the use of a machine learning clinical decision support system (ML-CDSS) to predict patients' risk of hepatic and renal deterioration during chemotherapy? A qualitative study. [PDF]

BMJ Open
Ercia A, Yip M, Reed C, Steventon L, Geoghegan C, Watson M, Kennelly C, Chambers P, Al Moubayed N.   +8 more
europepmc   +1 more source

Not all masses are metastases: a diagnostic dilemma resolved - synchronous HER2-positive breast cancer and renal oncocytoma. [PDF]

Int J Surg Case Rep
Shrivastava N, Mitra S, Pande S.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 2022
Elshad Hasanov, Debra Nana Yeboa, Todd A Swanson   +2 more
exaly  

Treatment of renal cell carcinoma: Current status and future directions

Ca-A Cancer Journal for Clinicians, 2017
Pedro C Barata
exaly  

Current management of renal cell carcinoma

Ca-A Cancer Journal for Clinicians, 1996
Jean B Dekernion, R A Figlin, Arie Belldegrun   +2 more
exaly